Literature DB >> 20619505

Sex differences in the association of the apolipoprotein E epsilon 4 allele with incidence of dementia, cognitive impairment, and decline.

May A Beydoun1, Adel Boueiz, Marwan S Abougergi, Melissa H Kitner-Triolo, Hind A Beydoun, Susan M Resnick, Richard O'Brien, Alan B Zonderman.   

Abstract

We examined longitudinal associations between the apolipoprotein E ε4 allele (ApoE4(+) status) and several cognitive outcomes and tested effect modification by sex. Data on 644 non-Hispanic Caucasian adults, from the Baltimore Longitudinal Study of Aging (BLSA) were used. Dementia onset, cognitive impairment and decline were assessed longitudinally. After 27.5 years median follow-up, 113 participants developed dementia. ApoE4(+) predicted dementia significantly (hazard ratio [HR] = 2.89; 95% confidence interval [CI], 1.93-4.33), with nonsignificant sex differences. Taking all time points for predicting cognition, women had significantly stronger positive associations than men between ApoE4(+) status and impairment or decline on the California Verbal Learning Test (CVLT; delayed recall and List A total recall) and on Verbal Fluency Test-Categories. This ApoE4 × sex interaction remained significant with Bonferroni correction only for CVLT-delayed recall. Taking time points prior to dementia for cognitive predictions, the positive association between impairment in CVLT-delayed recall and ApoE4(+) status remained stronger among women, though only before Bonferroni correction. While ApoE4(+) status appears to be a sex neutral risk factor for dementia, its association with verbal memory and learning decline and impairment was stronger among women. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20619505      PMCID: PMC2974952          DOI: 10.1016/j.neurobiolaging.2010.05.017

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  51 in total

1.  Cognitive function and apolipoprotein E in very old adults: findings from the Nun Study.

Authors:  K P Riley; D A Snowdon; A M Saunders; A D Roses; J A Mortimer; N Nanayakkara
Journal:  J Gerontol B Psychol Sci Soc Sci       Date:  2000-03       Impact factor: 4.077

2.  Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.

Authors:  Brian D Hoyt; Paul J Massman; Christopher Schatschneider; Norma Cooke; Rachelle S Doody
Journal:  Arch Neurol       Date:  2005-03

3.  The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects.

Authors:  G Blessed; B E Tomlinson; M Roth
Journal:  Br J Psychiatry       Date:  1968-07       Impact factor: 9.319

4.  Clinical dementia rating: a reliable and valid diagnostic and staging measure for dementia of the Alzheimer type.

Authors:  J C Morris
Journal:  Int Psychogeriatr       Date:  1997       Impact factor: 3.878

5.  Cognitive deficits and polymorphism of apolipoprotein E in Alzheimer's disease.

Authors:  Elizbieta Luczywek; Anna Nowicka; Anna Pfeffer; Krzysztof Czyzewski; Maria Styczyńska; Maciej Lałowski; Maria Barcikowska
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

6.  Major decrease in the volume of the entorhinal cortex in patients with Alzheimer's disease carrying the apolipoprotein E epsilon4 allele.

Authors:  K Juottonen; M Lehtovirta; S Helisalmi; P J Riekkinen; H Soininen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1998-09       Impact factor: 10.154

7.  The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period.

Authors:  Robert S Wilson; Julie A Schneider; Lisa L Barnes; Laurel A Beckett; Neelum T Aggarwal; Elizabeth J Cochran; Elizabeth Berry-Kravis; Julie Bach; Jacob H Fox; Denis A Evans; David A Bennett
Journal:  Arch Neurol       Date:  2002-07

8.  Apolipoprotein e4 allele and cognitive decline in elderly men.

Authors:  E J Feskens; L M Havekes; S Kalmijn; P de Knijff; L J Launer; D Kromhout
Journal:  BMJ       Date:  1994-11-05

9.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium.

Authors:  L A Farrer; L A Cupples; J L Haines; B Hyman; W A Kukull; R Mayeux; R H Myers; M A Pericak-Vance; N Risch; C M van Duijn
Journal:  JAMA       Date:  1997 Oct 22-29       Impact factor: 56.272

Review 10.  Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities.

Authors:  Angel Cedazo-Mínguez
Journal:  J Cell Mol Med       Date:  2007 Nov-Dec       Impact factor: 5.310

View more
  57 in total

1.  Olfactory ERPs in an odor/visual congruency task differentiate ApoE ε4 carriers from non-carriers.

Authors:  Joel Kowalewski; Claire Murphy
Journal:  Brain Res       Date:  2011-12-20       Impact factor: 3.252

Review 2.  Insights into Computational Drug Repurposing for Neurodegenerative Disease.

Authors:  Manish D Paranjpe; Alice Taubes; Marina Sirota
Journal:  Trends Pharmacol Sci       Date:  2019-07-17       Impact factor: 14.819

3.  Vitamin D Receptor and Megalin Gene Polymorphisms Are Associated with Longitudinal Cognitive Change among African-American Urban Adults.

Authors:  May A Beydoun; Salman M Tajuddin; Greg A Dore; Jose-Atilio Canas; Hind A Beydoun; Michele K Evans; Alan B Zonderman
Journal:  J Nutr       Date:  2017-04-26       Impact factor: 4.798

4.  Apolipoprotein E ε4 allele interacts with sex and cognitive status to influence all-cause and cause-specific mortality in U.S. older adults.

Authors:  May A Beydoun; Hind A Beydoun; Jay S Kaufman; Yang An; Susan M Resnick; Richard O'Brien; Luigi Ferrucci; Alan B Zonderman
Journal:  J Am Geriatr Soc       Date:  2013-03-21       Impact factor: 5.562

5.  Apolipoprotein E ε4 allele effects on longitudinal cognitive trajectories are sex and age dependent.

Authors:  Owen A Williams; Yang An; Nicole M Armstrong; Andrea T Shafer; Jessica Helphrey; Melissa Kitner-Triolo; Luigi Ferrucci; Susan M Resnick
Journal:  Alzheimers Dement       Date:  2019-09-24       Impact factor: 21.566

6.  Apolipoprotein E4 Causes Age-Dependent Disruption of Slow Gamma Oscillations during Hippocampal Sharp-Wave Ripples.

Authors:  Anna K Gillespie; Emily A Jones; Yuan-Hung Lin; Mattias P Karlsson; Kenneth Kay; Seo Yeon Yoon; Leslie M Tong; Philip Nova; Jessie S Carr; Loren M Frank; Yadong Huang
Journal:  Neuron       Date:  2016-05-05       Impact factor: 17.173

7.  Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis.

Authors:  Scott C Neu; Judy Pa; Walter Kukull; Duane Beekly; Amanda Kuzma; Prabhakaran Gangadharan; Li-San Wang; Klaus Romero; Stephen P Arneric; Alberto Redolfi; Daniele Orlandi; Giovanni B Frisoni; Rhoda Au; Sherral Devine; Sanford Auerbach; Ana Espinosa; Mercè Boada; Agustín Ruiz; Sterling C Johnson; Rebecca Koscik; Jiun-Jie Wang; Wen-Chuin Hsu; Yao-Liang Chen; Arthur W Toga
Journal:  JAMA Neurol       Date:  2017-10-01       Impact factor: 18.302

Review 8.  Sexual dimorphism in predisposition to Alzheimer's disease.

Authors:  Daniel W Fisher; David A Bennett; Hongxin Dong
Journal:  Neurobiol Aging       Date:  2018-04-17       Impact factor: 4.673

Review 9.  Understanding the impact of sex and gender in Alzheimer's disease: A call to action.

Authors:  Rebecca A Nebel; Neelum T Aggarwal; Lisa L Barnes; Aimee Gallagher; Jill M Goldstein; Kejal Kantarci; Monica P Mallampalli; Elizabeth C Mormino; Laura Scott; Wai Haung Yu; Pauline M Maki; Michelle M Mielke
Journal:  Alzheimers Dement       Date:  2018-06-12       Impact factor: 21.566

Review 10.  Apolipoprotein E, gender, and Alzheimer's disease: an overlooked, but potent and promising interaction.

Authors:  Leo Ungar; Andre Altmann; Michael D Greicius
Journal:  Brain Imaging Behav       Date:  2014-06       Impact factor: 3.978

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.